![Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences | Journal of Human Genetics Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences | Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs10038-007-0186-6/MediaObjects/10038_2007_186_Fig1_HTML.gif)
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences | Journal of Human Genetics
![JPM | Free Full-Text | DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients JPM | Free Full-Text | DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients](https://www.mdpi.com/jpm/jpm-08-00045/article_deploy/html/images/jpm-08-00045-g001.png)
JPM | Free Full-Text | DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients
![Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-021-02708-4/MediaObjects/12094_2021_2708_Fig1_HTML.png)
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
![DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis - The Lancet Oncology DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis - The Lancet Oncology](https://www.thelancet.com/cms/attachment/711d8627-84c3-4142-9b5e-f6310f7a3554/gr1_lrg.gif)
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis - The Lancet Oncology
UNIVERSITÀ DEGLI STUDI DI GENOVA TESI DI LAUREA APPLICAZIONE DELLE RACCOMANDAZIONI AIOM-SIF PER L'ANALISI FARMACOGENETICA DEL
![DPYD Gene Activity Score Predicts Dose-Limiting Toxicity in Fluoropyrimidine-Treated Colorectal Cancer Patients DPYD Gene Activity Score Predicts Dose-Limiting Toxicity in Fluoropyrimidine-Treated Colorectal Cancer Patients](https://article.imrpress.com/journal/JMCM/1/3/10.31083/j.jmcm.2018.03.003/2617-5282-1-3-143/img_1.png)
DPYD Gene Activity Score Predicts Dose-Limiting Toxicity in Fluoropyrimidine-Treated Colorectal Cancer Patients
![Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/14622416.8.3.257/asset/images/medium/graphic4.gif)
Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics
![Possible Associations of Splice Site Mutation of Dihydropyrimidine Dehydrogenase (IVS14+1G>A) in Adverse Drug Reactions in Some Invasive Ductal Carcinoma Patients Possible Associations of Splice Site Mutation of Dihydropyrimidine Dehydrogenase (IVS14+1G>A) in Adverse Drug Reactions in Some Invasive Ductal Carcinoma Patients](https://docsdrive.com/images/ansinet/ijp/2007/fig2-2k7-130-136.gif)
Possible Associations of Splice Site Mutation of Dihydropyrimidine Dehydrogenase (IVS14+1G>A) in Adverse Drug Reactions in Some Invasive Ductal Carcinoma Patients
![Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? | SpringerLink Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13167-010-0041-2/MediaObjects/13167_2010_41_Fig4_HTML.gif)
Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? | SpringerLink
![The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice - ScienceDirect The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960982221012896-fx1.jpg)
The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice - ScienceDirect
![Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines | European Journal of Human Genetics Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41431-019-0540-0/MediaObjects/41431_2019_540_Fig1_HTML.png)
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines | European Journal of Human Genetics
![DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation - Varughese - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation - Varughese - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and](https://accpjournals.onlinelibrary.wiley.com/cms/asset/49d74cd7-2bd8-450a-9398-2652f20c8111/phar2463-fig-0001-m.jpg)
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation - Varughese - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and
![Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity | British Journal of Cancer Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2013.262/MediaObjects/41416_2013_Article_BFbjc2013262_Fig1_HTML.jpg)
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity | British Journal of Cancer
![Functional effect of DPYD*2A (IVS14 ϩ 1G Ͼ A). The polymorphism DPYD... | Download Scientific Diagram Functional effect of DPYD*2A (IVS14 ϩ 1G Ͼ A). The polymorphism DPYD... | Download Scientific Diagram](https://www.researchgate.net/publication/51183766/figure/fig2/AS:277270766866434@1443117910125/Functional-effect-of-DPYD2A-IVS14-1G-A-The-polymorphism-DPYD-IVS14-1G-A-is-a.png)